Dr. Abushamat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge Street, A10-187
Mail Stop: BCM-903
Houston, TX 77030
Summary
- Dr. Farid Abushamat is a gastroenterologist based in Houston, TX. He completed his medical education at Tulane University School of Medicine in 2018, following which he pursued a residency in Internal Medicine at the University of California (San Diego) Medical Center until 2021. From 2021 to 2024, Dr. Abushamat was a Gastroenterology Fellow at the Baylor College of Medicine. He has been credited with numerous publications in recognized medical journals, including the Journal of Ultrasound in Medicine, Clinics in Liver Disease, Clinical Journal of Gastroenterology, and Heartrhythm Case Reports. His papers cover a range of topics including ultrasound evaluations, liver disease, graft loss rejection, and sudden cardiac death due to immune checkpoint inhibitor-associated myocarditis.
Education & Training
Baylor College of MedicineFellowship, Gastroenterology, 2021 - 2024
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2018 - 2021
Tulane University School of MedicineClass of 2018, MD
Rice UniversityBA, 2010 - 2014
Certifications & Licensure
TX State Medical License 2022 - 2026
CA State Medical License 2019 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 12 citationsComplete heart block and subsequent sudden cardiac death from immune checkpoint inhibitor-associated myocarditis.Shaun Giancaterino, Farid Abushamat, Jason M. Duran, Florentino Lupercio, Anthony N. DeMaria
Heartrhythm Case Reports. 2020-07-25 - 19 citationsRescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.Yalda Dehghan, Gabriel T. Schnickel, Mojgan Hosseini, Adam M. Burgoyne, Veeral Ajmera
Clinical Journal of Gastroenterology. 2021-10-13 - 7 citationsImaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How?Guilherme Moura Cunha, Kathryn J. Fowler, Farid Abushamat, Claude B. Sirlin, Yuko Kono
Clinics in Liver Disease. 2020-09-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
